EP3071202A1 — A combination of dosage units for use in the treatment of pre-term labour condition
Assigned to Laboratorio Reig Jofre SA · Expires 2016-09-28 · 10y expired
What this patent protects
A combination of dosage units for use in the treatment of pre-term labour condition The invention refers to a combination of dosage units of a pharmaceutical or veterinary liquid composition for oral administration for use in the treatment of pre-term labour condition, wherein th…
USPTO Abstract
A combination of dosage units for use in the treatment of pre-term labour condition The invention refers to a combination of dosage units of a pharmaceutical or veterinary liquid composition for oral administration for use in the treatment of pre-term labour condition, wherein the treatment comprises administering to a female mammal: (a) First, a dosage unit of the pharmaceutical or veterinary liquid composition comprising 10 mg of nifedipine; followed by (b) From 1 to 4 dosage units of the pharmaceutical or veterinary liquid composition comprising each 7.5 mg of nifedipine, each dosage unit being sequentially administered at an appropriate time period; and wherein the maximum amount of nifedipine administered in a period of an hour is comprised from 17.5 mg to 40 mg.
Drugs covered by this patent
- Cozaar (LOSARTAN POTASSIUM) · Merck & Co.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.